ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

LIFC Lifecell Corp (MM)

51.05
0.00 (0.00%)
Pre Market
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Lifecell Corp (MM) NASDAQ:LIFC NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 51.05 0 01:00:00

LifeCell Corporation Schedules First Quarter 2008 Financial Results Conference Call; April 24, 2008 at 10:00 A.M. Eastern

17/04/2008 10:08pm

PR Newswire (US)


Lifecell Corp (MM) (NASDAQ:LIFC)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Lifecell Corp (MM) Charts.
BRANCHBURG, N.J., April 17 /PRNewswire-FirstCall/ -- LifeCell Corporation (NASDAQ:LIFC), today announced plans to release first quarter 2008 operating results on Thursday, April 24, 2008 at 8:00 a.m. Eastern. Paul Thomas, President and Chief Executive Officer, will host a conference call at 10:00 a.m. Eastern, to discuss the Company's first quarter 2008 financial results. The dial-in number for the live call is (877) 591-4951/domestic or (719) 325-4880/international. A simultaneous webcast of the call will be available via LifeCell's website at http://www.lifecell.com/ Corporate Information - Investor Relations. The call will be archived on the Company's website for at least 90 days. A recording of the live-call will be available through May 1, 2008. The dial-in number to listen to the recording is (888) 203-1112 or (719) 457-0820. The replay access code is 3074049. About LifeCell LifeCell is the leading provider of innovative biological products for soft tissue repair. Surgeons use our products to restore structure, function and physiology in a variety of reconstructive, orthopedic and urogynecologic surgical procedures. LifeCell's products include: ALLODERM(R) regenerative tissue matrix, for plastic reconstructive, general surgical, burn and periodontal procedures; STRATTICE(TM) reconstructive tissue matrix, for plastic reconstructive and general surgical procedures; GRAFTJACKET(R) regenerative tissue matrix, for orthopedic applications and lower extremity wounds; ALLOCRAFT(R)DBM, for bone grafting procedures; and REPLIFORM(R) tissue regeneration matrix for urogynecologic surgical procedures. The Company's research and development initiatives include programs designed to extend the use of its current marketed products into new surgical applications as well as expanding its product line in the rapidly growing biosurgery market. LifeCell maintains a website at http://www.lifecell.com/. DATASOURCE: LifeCell Corporation CONTACT: Steven T. Sobieski, Chief Financial Officer of LifeCell Corporation, +1-908-947-1106, ; or Kevin McGrath of Cameron Associates, +1-212-245-8800, Web site: http://www.lifecell.com/

Copyright

1 Year Lifecell Corp (MM) Chart

1 Year Lifecell Corp (MM) Chart

1 Month Lifecell Corp (MM) Chart

1 Month Lifecell Corp (MM) Chart

Your Recent History

Delayed Upgrade Clock